Brandon Hall Group to Launch Study on Workforce Reduction
The Impact of Workforce Reductions...
Globe Newswire14-03-2023, 03:18
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami 15-04-2024, 19:00